Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from China
Abstract. Background:. In China, the prevalence of allergic rhinitis (AR) and asthma has increased in the past decade. As these two diseases frequently coexist, the Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR) study aimed to assess physicians’ beliefs and treatment patt...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2019-06-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000000229 |
id |
doaj-700a02a42c91465eb96c42ffd9ac4960 |
---|---|
record_format |
Article |
spelling |
doaj-700a02a42c91465eb96c42ffd9ac49602020-12-02T07:47:56ZengWolters KluwerChinese Medical Journal0366-69992542-56412019-06-01132111264127110.1097/CM9.0000000000000229201906050-00002Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from ChinaDavid HindsBhumika AggarwalXin DuAruni MulgirigamaSumitra ShantakumarXin ChenAbstract. Background:. In China, the prevalence of allergic rhinitis (AR) and asthma has increased in the past decade. As these two diseases frequently coexist, the Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR) study aimed to assess physicians’ beliefs and treatment patterns of coexistent asthma-AR across six Asian countries. This analysis presents the results from China. Methods:. The 200 hospital-based general physicians and pediatricians were interviewed from five cities in China. Physicians were questioned in-person about their knowledge, beliefs and management practices for patients with coexistent asthma-AR. Results:. Approximately 70% of the physicians interviewed routinely evaluated their patients with asthma or AR for signs of coexistent disease. While the majority of physicians (>90% of physicians) recognized the increased burden of coexistent asthma-AR vs. one condition alone and that coexistent disease requires additional treatment, most physicians (96%) also believed that patients with coexistent asthma-AR were well managed if either condition alone improved. Similarly, although 71% of physicians selected a combination of intranasal and inhaled corticosteroids as their preferred treatment for coexistent asthma-AR, in line with treatment guidelines, two fifths of physicians indicated that treatment for coexistent disease requires too much medication and that their patients prefer oral medications and a third of physicians believed that corticosteroids should be delayed in children. Conclusions:. This survey demonstrates that physicians interviewed in China have a broad understanding of coexistent asthma-AR and its impact on patients. A holistic approach to patient management with informed decisions regarding patients’ overall treatment will benefit patients who suffer from coexistent disease.http://journals.lww.com/10.1097/CM9.0000000000000229 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David Hinds Bhumika Aggarwal Xin Du Aruni Mulgirigama Sumitra Shantakumar Xin Chen |
spellingShingle |
David Hinds Bhumika Aggarwal Xin Du Aruni Mulgirigama Sumitra Shantakumar Xin Chen Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from China Chinese Medical Journal |
author_facet |
David Hinds Bhumika Aggarwal Xin Du Aruni Mulgirigama Sumitra Shantakumar Xin Chen |
author_sort |
David Hinds |
title |
Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from China |
title_short |
Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from China |
title_full |
Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from China |
title_fullStr |
Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from China |
title_full_unstemmed |
Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from China |
title_sort |
asia pacific survey of physicians on asthma and allergic rhinitis (aspair): data from china |
publisher |
Wolters Kluwer |
series |
Chinese Medical Journal |
issn |
0366-6999 2542-5641 |
publishDate |
2019-06-01 |
description |
Abstract. Background:. In China, the prevalence of allergic rhinitis (AR) and asthma has increased in the past decade. As these two diseases frequently coexist, the Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR) study aimed to assess physicians’ beliefs and treatment patterns of coexistent asthma-AR across six Asian countries. This analysis presents the results from China.
Methods:. The 200 hospital-based general physicians and pediatricians were interviewed from five cities in China. Physicians were questioned in-person about their knowledge, beliefs and management practices for patients with coexistent asthma-AR.
Results:. Approximately 70% of the physicians interviewed routinely evaluated their patients with asthma or AR for signs of coexistent disease. While the majority of physicians (>90% of physicians) recognized the increased burden of coexistent asthma-AR vs. one condition alone and that coexistent disease requires additional treatment, most physicians (96%) also believed that patients with coexistent asthma-AR were well managed if either condition alone improved. Similarly, although 71% of physicians selected a combination of intranasal and inhaled corticosteroids as their preferred treatment for coexistent asthma-AR, in line with treatment guidelines, two fifths of physicians indicated that treatment for coexistent disease requires too much medication and that their patients prefer oral medications and a third of physicians believed that corticosteroids should be delayed in children.
Conclusions:. This survey demonstrates that physicians interviewed in China have a broad understanding of coexistent asthma-AR and its impact on patients. A holistic approach to patient management with informed decisions regarding patients’ overall treatment will benefit patients who suffer from coexistent disease. |
url |
http://journals.lww.com/10.1097/CM9.0000000000000229 |
work_keys_str_mv |
AT davidhinds asiapacificsurveyofphysiciansonasthmaandallergicrhinitisaspairdatafromchina AT bhumikaaggarwal asiapacificsurveyofphysiciansonasthmaandallergicrhinitisaspairdatafromchina AT xindu asiapacificsurveyofphysiciansonasthmaandallergicrhinitisaspairdatafromchina AT arunimulgirigama asiapacificsurveyofphysiciansonasthmaandallergicrhinitisaspairdatafromchina AT sumitrashantakumar asiapacificsurveyofphysiciansonasthmaandallergicrhinitisaspairdatafromchina AT xinchen asiapacificsurveyofphysiciansonasthmaandallergicrhinitisaspairdatafromchina |
_version_ |
1724408122476331008 |